Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04221373 · ClinicalTrials.gov registry record · NA
Exoskeletal-Assisted Walking in SCI Acute Inpatient Rehabilitation
A NA study, sponsored by Icahn School of Medicine at Mount Sinai.
- Completed
- Registry status
- NA
- Development phase
- 32
- Enrollment target
NCT04221373 is a NA study that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 32 participants.
The verdict
NCT04221373, a NA study, has completed, sponsored by Icahn School of Medicine at Mount Sinai.
- COMPLETED
- Registry status
- NA
- Development phase
- 32 participants
- Enrollment target
Study Summary
The purpose of this research study is to test the effect of early exoskeletal-assisted walking (EAW) training (combined into regular acute inpatient rehabilitation (AIR)) on improving functional recovery and reducing pain and inflammation. Powered exoskeletons are a technology that offer standing and walking for certain persons with spinal cord injury (SCI) who meet the using indication of the device and have been used in the chronic SCI population with positive benefits in ability to move, daily function (such as bathing and dressing), body composition (such as lean and fat tissue mass), and quality of life (QOL). Despite the potential for EAW to promote functional recovery and reduce secondary medical complications (such as urinary tract infections and pain), no reports exist on the use of exoskeletons in AIR.
Interventions
- OTHER Standard of care
- DEVICE Ekso™ powered exoskeleton
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2019-09-30 |
| Est. Completion | 2022-09-13 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04221373
The ClinicalTrials.gov registry entry for NCT04221373 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Standard of care is the first listed.
NCT04221373 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04221373 about?
NCT04221373 is a clinical study titled "Exoskeletal-Assisted Walking in SCI Acute Inpatient Rehabilitation". The purpose of this research study is to test the effect of early exoskeletal-assisted walking (EAW) training (combined into regular acute inpatient rehabilitation (AIR)) on improving functional recovery and reducing pain and inflammation. Powered exoskeletons are a technology that offer standing an...
What is the current status of trial NCT04221373?
This trial is currently completed. It is a NA study. The enrollment target is 32 participants. The study started on 2019-09-30. Estimated completion is 2022-09-13.
What interventions are being tested in trial NCT04221373?
The interventions under investigation include: Standard of care (OTHER), Ekso™ powered exoskeleton (DEVICE).
Who is sponsoring clinical trial NCT04221373?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.